The Jackson Laboratory has received a $3.4 million grant from the California Institute for Regenerative Medicine (CIRM), the state’s stem cell agency, to help speed the development of new therapies for cancer, Alzheimer’s, Parkinson’s and other diseases.
The nonprofit Jackson Laboratory, based in Bar Harbor, has a facility in Sacramento that provides research services to the West Coast biomedical community. The Jackson Laboratory—West will use the CIRM grant to develop new mouse models of human disease that can be used to test innovative stem cell treatments.
Jackson Laboratory President and CEO Rick Woychik, Ph.D., says, “Stem cells have tremendous potential for treating human diseases because of their unique capacity to develop into any cell type in the body. However, before stem cell therapies are used in human patients, it is critical to test their efficacy and safety using a research animal that has the relevant disease.”
The laboratory mouse, widely recognized as the premier mammalian model for studying human disease, is the optimal organism for these preclinical studies, Woychik says.
CIRM issued the award as part of a $40.6 million package of new and continuing grants to California universities and public and private research laboratories. The Jackson project is among those CIRM describes as “early translational” and “intended to either lead to a drug candidate for an unmet medical need or address a bottleneck in the development of new therapies.”
Woychik notes that the grant illustrates the value of having established a presence for the Laboratory in California. “Being located in the world’s largest biomedical research community brings us opportunities that would otherwise be unavailable to us,” he says. “This grant, like more than 90 percent of our funding, comes from outside Maine.”
Leon Hall, Ph.D., is a program director of The Jackson Laboratory—West group that will develop the new mouse models. While mouse models are available for a wide range of human diseases, Hall says, “The Jackson Laboratory now has immune-deficient mice that support long-term transplantation with human stem cells. This grant will allow us to develop new and more relevant mouse models of disease that can sustain human stem cell engraftment. This should eliminate a major barrier to the translation of basic stem cell research to the clinic.”
Chuck Hewett, Ph.D., Jackson VP and chief operating officer, added that “once these new models are developed, The Jackson Laboratory—West will use its new, state-of-the-art facilities to ensure efficient delivery of these mice within California and to provide services to stem cell investigators to reveal information about disease progression.”
The Jackson Laboratory established JAX—West at a small facility in West Sacramento in 2001. In late 2008 JAX—West moved to a larger facility in Sacramento, with about 85 employees on site. Providing a pathogen-free environment for the laboratory animals, the facility meets the highest federal, state and voluntary standards for animal care, genetic quality control and health status, Hewett notes.
Joyce Peterson | Newswise Science News
Yuan Chang and Patrick Moore win prize for the discovery of two cancer viruses
14.03.2017 | Goethe-Universität Frankfurt am Main
BMBF funding for diabetes research on pancreas chip
08.02.2017 | Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt
Astronomers from Bonn and Tautenburg in Thuringia (Germany) used the 100-m radio telescope at Effelsberg to observe several galaxy clusters. At the edges of these large accumulations of dark matter, stellar systems (galaxies), hot gas, and charged particles, they found magnetic fields that are exceptionally ordered over distances of many million light years. This makes them the most extended magnetic fields in the universe known so far.
The results will be published on March 22 in the journal „Astronomy & Astrophysics“.
Galaxy clusters are the largest gravitationally bound structures in the universe. With a typical extent of about 10 million light years, i.e. 100 times the...
Researchers at the Goethe University Frankfurt, together with partners from the University of Tübingen in Germany and Queen Mary University as well as Francis Crick Institute from London (UK) have developed a novel technology to decipher the secret ubiquitin code.
Ubiquitin is a small protein that can be linked to other cellular proteins, thereby controlling and modulating their functions. The attachment occurs in many...
In the eternal search for next generation high-efficiency solar cells and LEDs, scientists at Los Alamos National Laboratory and their partners are creating...
Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are less stable. Now researchers at the Technical University of Munich (TUM) have, for the first time ever, produced a composite material combining silicon nanosheets and a polymer that is both UV-resistant and easy to process. This brings the scientists a significant step closer to industrial applications like flexible displays and photosensors.
Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are...
Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to simulate these confined natural conditions in artificial vesicles for the first time. As reported in the academic journal Small, the results are offering better insight into the development of nanoreactors and artificial organelles.
Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to...
20.03.2017 | Event News
14.03.2017 | Event News
07.03.2017 | Event News
24.03.2017 | Materials Sciences
24.03.2017 | Physics and Astronomy
24.03.2017 | Physics and Astronomy